Jobs Tenders Contact Us
Skip Navigation LinksHome > Divisions > Animal Health Divisions > Veterinary Biotechnology Division > Major Achievements

Major Achievements

  • Developed subviral particle based infectious bursal disease (IBD) vaccine for chickens
  • Developed gene-deleted bovine herpesvirus-1 (BoHV-1) as infectious bovine rhinotracheitis (IBR) marker vaccine candidate
  • Developed Newcastle disease virus (NDV) strain R2B as a viral vector for vectored vaccine
  • Developed recombinant antigen-based ELISA for sero-diagnosis of infectious bursal disease (IBD) and Newcastle disease (ND) of chickens
  • Developed classical swine fever virus (CSFV) capsid, E1 and E2 structural proteins as virus-like particles (VLPs) for DIVA-based CSFV marker vaccine candidate
  • Established porcine induced pluripotent stem (iPS) cells and mesenchymal stem cell (MSC) lines from bone marrow, umbilical cord and adipose tissues
  • Developed multiplex bead based assay for detecting serum biomarkers associated with canine mammary tumours (CMT)
  • Developed a self-replicating RNA-replicon-based RNA vaccine vector (pAlpha-MCS) for heterologous gene expression in mammalian cells and immune responses
  • Completed genome sequencing of animal viruses, including bovine alphaherpesvirus 1 (KY215944), Classical swine fever virus-lapinized (EU857642) and field (KM262189) strains, Newcastle disease virus-mesogenic R2B (JX316216), lentogenic F (KC987036) vaccine and field (KJ769262) strains, Peste des petitis ruminants (PPR) virus Sungri/96 vaccine strain (KF727981)
  • Four patents (Patent Nos. 325899, 278655, 278622, 277404) have been granted